COMMON QUESTIONS
Everything you need to know before your first visit.
If something isn’t answered here, reach out directly — we’re happy to help you figure out if Long View Health is the right fit.
Yes. Long View Health is currently in network with Medicare, Aetna, CareFirst BCBS MD, and United Healthcare. Coverage varies by plan and service — please contact us to confirm your specific plan is accepted, as our network continues to expand. All patients pay their applicable copay at the time of booking. Cash-pay is also available, and all fees are HSA/FSA eligible.
The Long View Program is $150/month for six months. For insurance patients, individual clinical visits are billed to your insurance — you pay your applicable copay. The program fee covers the coaching calls, behavioral health curriculum, experiment trackers, and asynchronous messaging, which are not separately billable to insurance. The program fee is HSA/FSA eligible. Self-pay patients pay a $150 deposit at booking, applied to their first month.
No referral is required to schedule a consultation. Many patients come directly; many are referred by their primary care physicians, cardiologists, or other specialist. Either path is welcome. If you’re using insurance, we’ll confirm your eligibility after your initial consultation depending on fit for our program.
Excess weight — particularly visceral fat — is one of the most significant drivers of chronic disease risk. It contributes directly to insulin resistance, elevated cardiovascular risk, systemic inflammation, dyslipidemia, and hormonal disruption. For many patients, it is the upstream cause of conditions they’re already managing: prediabetes, high blood pressure, abnormal cholesterol, sleep apnea, and joint disease. The mechanical load of excess weight accelerates cartilage breakdown in the knees, hips, and spine — but inflammation plays an equal role, driving joint deterioration even independent of weight bearing. Many patients find that metabolic improvements reduce joint pain in ways that go beyond what weight loss alone would predict.
The goal at Long View Health is never aesthetic. It’s metabolic. Reducing visceral fat, preserving lean muscle, and improving insulin sensitivity have measurable downstream effects on long-term health — including cardiovascular disease risk, cognitive function, joint health, and quality of life as you age. The scale is one data point. It is not the whole picture.
Medications like GLP-1 agonists are genuinely effective tools — but the evidence is consistent: outcomes are meaningfully better when medication is paired with structured behavioral support. In the landmark STEP 1 trial published in the New England Journal of Medicine, patients on semaglutide plus lifestyle intervention lost nearly 15% of body weight — compared to around 2% with lifestyle support alone. Real-world data without structured behavioral support shows results considerably more modest than clinical trials, averaging 8–12% weight loss versus 12–20% in structured settings (StatPearls, 2025).
The harder problem is what happens when medication stops. The STEP 1 extension and SURMOUNT-4 trials both demonstrated substantial weight regain after discontinuation — with one Oxford University meta-analysis of 37 trials finding that patients regained weight at roughly 0.4 kg per month after stopping, returning to near-baseline within about 1.7 years. Cardiometabolic markers — cholesterol, blood pressure, blood sugar — returned to baseline even faster.
Long View Health is built specifically around this gap. The clinical care and The Long View Program run in parallel so that by the time medication is reduced or stopped, the behavioral foundations have had time to take root.
Long View Health is a good fit if you’re managing insulin resistance, prediabetes, cardiometabolic risk factors, or hormonal changes affecting your metabolism — including weight that hasn’t responded to diet and exercise alone. The patients who do best here are motivated to engage with both the clinical and behavioral sides of care. You don’t need to have everything figured out before you reach out. That’s what the consultation is for.
You’re not alone — and your history of trying isn’t a character flaw. Obesity and metabolic dysfunction have real biological drivers: hormonal, genetic, neurological. For many patients, willpower and discipline were never the missing ingredient. The biology was working against them.
What’s different here is that we address both sides simultaneously — the clinical picture that may have been missed or undertreated, and the behavioral patterns that determine whether results last. We don’t assume you haven’t tried hard enough. We start by understanding why what you’ve tried hasn’t held and build from there.
Not by the scale alone. Weight is one data point — but it’s an incomplete one, particularly for patients on GLP-1 medications, which can cause muscle loss alongside fat loss. At Long View Health, progress is tracked across several dimensions: lab values — including nutritional status, since appetite suppression can quietly mask deficiencies in protein, B12, iron, magnesium, and vitamin D over time — body composition (fat mass, lean muscle, visceral fat), energy, sleep, and the behavioral domains we’re working on together in The Long View Program.
Progress is formally reviewed at two structured checkpoints: a 6-Month Metabolic Review at program completion — repeat labs, clinical metrics compared to baseline, behavioral domain review, and a finalized maintenance plan — and an Annual Metabolic Review each year thereafter. Because health changes, life changes, and your care should change with it.
No. Long View Health is a specialty practice focused on metabolic health, medical weight management, and hormonal care. We are not a primary care replacement and do not manage acute illness. We coordinate closely with your existing PCP — sharing clinical summaries after your intake and at key program milestones.
Care may include support for overweight and obesity, insulin resistance, prediabetes, metabolic syndrome, dyslipidemia, cardiometabolic risk factors, and hormonal changes related to perimenopause and menopause. If your needs fall outside our scope, we’ll refer you to an appropriate provider.
Hormonal changes — particularly those related to perimenopause and menopause — can significantly affect metabolism, weight distribution, sleep, and energy. These are clinically relevant factors that we assess and address as part of metabolic care.
Hormone replacement therapy (HRT) is part of the conversation when clinically appropriate. If you’re experiencing symptoms of perimenopause or menopause alongside metabolic concerns, that intersection is something we take seriously and evaluate thoroughly — not something that gets dismissed or referred out reflexively.
Long View Health is a telehealth-first practice, serving patients throughout Maryland. In-home visits with body composition analysis are available as an optional add-on for patients in Montgomery County.
Most medical weight loss programs do one thing well — either clinical management or lifestyle support. Long View Health does both. Meghan holds prescribing authority as an FNP-BC and advanced health coaching certification through the Dr. Sears Wellness Institute, with a background in integrative cardiac care that informs how she approaches cardiovascular and metabolic risk. Care is intentionally unhurried, grounded in evidence, and built for the long term — not the short-term scale result.
Yes, when clinically appropriate. FDA-approved GLP-1–based therapies — including semaglutide and tirzepatide — may be part of a comprehensive medical weight management plan. Medication is one tool within a broader strategy. We do not prescribe GLP-1s in isolation — they are integrated into a structured program with lifestyle support and ongoing monitoring.
Depending on your clinical picture, other FDA-approved options may be considered — including metformin (for prediabetes and insulin resistance), phentermine/topiramate, naltrexone/bupropion, and others. The right medication — or the decision not to use one — is based on your full evaluation, not a protocol.
We regularly see patients already on GLP-1 therapy who want more comprehensive support. We can take over prescribing and provide the clinical oversight, lifestyle curriculum, and body composition monitoring that optimizes outcomes — particularly around muscle preservation and long-term maintenance.
It depends — and anyone who gives you a fixed answer without knowing your full picture isn’t being transparent with you.
For some patients, medication is a time-limited tool: it creates the biological conditions for change while behavioral habits take root. As those habits solidify and metabolic health improves, it may be possible to reduce or stop medication with results that hold.
For others, obesity and metabolic dysfunction have strong physiological drivers — genetic, hormonal, neurological — that don’t resolve with behavior change alone. For those patients, ongoing medication may be part of long-term management, the same way a patient with hypertension or hypothyroidism stays on treatment that’s working.
What we try to avoid is the most common pattern: medication without behavioral scaffolding, followed by discontinuation, followed by regain. The Long View Program runs alongside your clinical care specifically so that if and when medication is reduced, the foundations are already in place. The goal is always the least medication necessary to sustain the best outcome — and we revisit that question together over time.
Body composition analysis uses bioelectrical impedance to measure body fat percentage, lean muscle mass, visceral fat, and hydration status — giving a far more complete clinical picture than scale weight or BMI alone. It’s particularly important for patients on GLP-1 medications, which can cause muscle loss alongside fat loss. Tracking body composition over time helps ensure you’re preserving muscle — a key determinant of long-term metabolic health and weight maintenance.
In-home body composition analysis is available as an optional add-on for $175, for patients in Montgomery County. Meghan comes to you — no clinic visit required. It can be scheduled as a standalone appointment or alongside a clinical visit.
For ongoing tracking between visits, a home bioelectrical impedance scale is a practical option. Look for one that measures body fat percentage, muscle mass, and visceral fat — not just weight. Withings and Renpho both make reliable consumer options at different price points. We’re happy to make a specific recommendation based on your situation.
GET STARTED
Still have questions?
Schedule a consultation — no obligation, just a conversation.